I'm surprised that the staff cost still increased by about 5% over the last qtr. Wasn't this supposed to be a consolidation phase for staff levels after the completion of the industrialisation of the Unifill Syringe?
Also, can someone tell me where to find sales forecast numbers. I'm not sure how to read the 1.451m receipts. Is this inline with expectations? I was expecting more - not sure if I should have.